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Abstract
Fatty acids are important molecules with multiple biological properties. Emerging
evidence suggests that fatty acids can modulate autophagy. Saturated fatty acids
contribute to pancreatic β-cell dysfunction in type 2 diabetes. Palmitic acid, one of the
long-chain saturated fatty acids (LCFA), induces autophagy of β-cells which protects
them from dysfunctions and apoptotic cell death. Short-chain fatty acids (SCFA)
possess antitumor activity in colon cancer cells by promoting autophagy. SCFAs can
induce autophagy by suppressing the activity of mTOR signaling. As the most
common monosaturated fatty acid (MUFA) in daily nutrition, oleic acid could induce
autophagy, which is responsible for the regulation of lipids metabolism in hepato‐
cytes. The ω-3 and ω-6 polyunsaturated fatty acids (PUFA) are essential in normal
physiology and metabolism and play a contributory role in the incidence and progress
of a series of disease including cancer. Autophagy triggered by ω-3 PUFAs contributes
to the cytotoxicity in cancer cells by enhancing apoptosis, while autophagy mediated
by ω-6 PUFAs led to the increase in Caenorhabditis elegans lifespan. The recent findings
illustrate the potential involvement of autophagy regulation by fatty acids in a number
of biological and pathological processes.
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1. Introduction
Fatty acids are aliphatic carboxylic acids consisting of a hydrocarbon chain and a terminal
carboxyl group. Fatty acids are classified as several groups with respect to their structure and
biological functions. Saturated fatty acids, which have no double bond between individual
carbon atoms of the hydrocarbon chain, are divided into short-chain fatty acids (SCFA),
medium-chain fatty acids (MCFA), long-chain fatty acids (LCFA), and very long-chain fatty
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acids (VLCFA) according to their chain length. The introduction of double bonds in the
hydrocarbon chain results in the formation of the unsaturated fatty acids. Monounsaturated
fatty acids (MUFA) have only one carbon–carbon double bond which can occur in different
positions. Polyunsaturated fatty acids (PUFA) contain two or more double bonds along their
carbon backbones. PUFAs are classified into subgroups including ω-3 and ω-6 PUFAs
according to the position of the first double bond starting from methyl end.
Fatty acids provided by diets are ingested as triglycerides and then broken down into free fatty
acids and monoglycerides for absorption in small intestine. In the intestinal mucosa cells, free
fatty acids are re-esterified to triglycerides which are transported via lymphatic vessels to
circulation as part of chylomicrons. Eventually, they bind to the membranes of hepatocytes,
adipocytes, or muscle fibers where they are either stored or oxidized for supplying energy.
Apart from serving as important energy substrates, fatty acids have multiple biological
functions. The ω-3 and ω-6 PUFAs are essential in normal physiology and metabolism through
their roles in membrane structural lipids, signal transduction pathways, eicosanoids metabo‐
lism, and gene expression. Saturated fatty acids have been related to adverse health effects
whereas unsaturated fatty acids, especially monounsaturated and ω-3 polyunsaturated, are
thought to be protective. In addition, trans fatty acids have been shown to play a negative role
on health whereas conjugated fatty acids might be beneficial [1].
Autophagy is a catabolic process in which cytoplasmic components are sequestered in double-
membrane vesicles and degraded by fusion with lysosomal compartments. The process of
autophagy begins with the formation and elongation of phagophores. The cytoplasmic cargo
is then sequestered and the double-membrane autophagosome fuses with a lysosome to
generate the autolysosome. Finally, degradation is achieved through the hydrolytic enzymes
within the autolysosome [2]. Autophagy maintains cellular homeostasis by eliminating
superfluous or damaged proteins and organelles as well as provides substrates for energy
generation and biosynthesis. Deregulation of autophagy is linked with susceptibility to various
disorders including degenerative diseases, metabolic syndrome, aging, infectious diseases,
and tumorigenesis.
Emerging evidence indicates the ability of fatty acids to induce autophagy. Mice fed with a
high-fat diet lead to the formation of double-membrane autophagosomes in livers and increase
the level of LC3-II which serve as a marker of autophagosome formation and the activity of
autophagic flux [3]. Autophagy has been demonstrated to be involved in the biological
function of fatty acids. Our recent studies reported that SCFAs promote autophagy in colon
cancer cells which serves as an adaptive strategy for retarding apoptotic cell death [4]. In this
chapter, the regulation of autophagy by fatty acids will be discussed including the mechanism
of action involved and the biological significance implicated.
2. Saturated fatty acids
Saturated fatty acids are saturated with hydrogen and can be divided into subgroups according
to their chain length. LCFAs increase levels of low-density lipoprotein-cholesterol, which is
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connected with pathogenesis in multiple organs. SCFAs influence a wide array of cellular
functions, especially affecting colonic health. Autophagy triggered by LCFAs in pancreatic β-
cell and cardiomyocytes plays a critical role in the molecular pathogenesis of lipotoxicity.
SCFAs induce autophagy in colon cancer and protect against mitochondria-mediated apop‐
totic cell death.
2.1. Long-chain saturated fatty acids
2.1.1. Palmitic acid
Palmitic acid (16:0) is the most abundant free saturated fatty acid in bloodstream. As its
name indicates, it  is a major component of the palm oil but also be found in meats and
diary products. The stimulatory effect of palmitic acid on autophagy has been extensively
examined in rat pancreatic beta cell INS-1 and has also been observed in human pancreat‐
ic islet and many other human cell lines including in neuroblastoma, myoblasts, hepato‐
cytes, and endothelial cells [5-7]. After exposure to palmitic acid, INS-1 cells displayed a
marked  increase  in  the  number  of  typical  autophagosomes  characterized  by  double-
membranous  vacuoles  engulfing  cytoplasmic  structures.  When  monodansylcadaverine
(MDC) was used to label autophagic vacuoles, the proportion of cells with MDC-stained
dots dramatically increased after palmitic acid treatment. In GFP-LC3-expressed INS-1 cells,
the number of GFP-LC3 puncta began to increase from 6 h after palmitic acid treatment
and size of the dots gradually increased during palmitic acid incubation [5]. Autophagic
flux was also accelerated by palmitic acid as evidenced by the enhanced conversion of LC3-
I to LC3-II and the fusion between autophagosome and lysosomes. During autophagy, long-
lived  proteins  were  engulfed  by  autophagosomes  and  delivered  to  the  lysosomes  for
degradation. The degradation rate of long-lived protein significantly increased in palmitate-
treated  cells.  When  autophagy  was  suppressed  by  ATG7  knockdown  with  siRNA,  the
proteolytic rate induced by palmitic acid significantly declined [6].
While mammalian target of rapamycin (mTOR) has been well established as the key regulator
of the autophagic process, palmitic acid does not change phosphorylated status level of mTOR
or its substrate p70S6K, suggesting that autophagy triggered by palmitic acid is mTOR-
independent [8]. c-Jun N-terminal kinases (JNK) have been implicated in the induction of
autophagy by various stimuli including starvation, cytokine stimulation, and endoplasmic
reticulum (ER) stress. One mechanism by which JNK contributes to autophagy involves
phosphorylation of the antiapoptotic protein Bcl-2. Phosphorylation of Bcl-2 by JNK causes its
dissociation from Beclin-1 resulting in induction of autophagy. In addition, JNK could regulate
autophagy by enhancing the expression of autophagic genes including Beclin-1, ATG5, and
ATG7 [9]. JNK1 was phosphorylated shortly after exposure to palmitate in INS-1 cells, and
inhibition of JNK with chemical inhibitor or molecular methods significantly decreased
palmitate-induced conversion of LC3-I to LC3-II, indicating that JNK1 activation is responsible
for palmitic-acid-triggered autophagy [6,10].
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Another kinase involved in palmitate-induced autophagy is protein kinase C (PKC). There are
10 PKC isoenzymes classified as conventional, novel, and atypical in mammalian system.
Several PKC isoenzymes including PCKδ, PKCθ, and PCKα have been implicated in autoph‐
agy. When taken up by cells, excess free fatty acids are converted into acyl-coA derivatives
which can be incorporated and stored in the cells as neutral lipids like diacylglycerol (DAG)
and triacylglycerol (TAG). Treatment with palmitic acid resulted in an increase in the relative
levels of DAG, which serves as a natural agonist to recruit PKC proteins to plasma membrane
for activation [11]. Conventional PKCα has been demonstrated to be activated and responsible
for the autophagy by palmitic acid as evidenced by the following observations:
1. The formation of GFP-LC3 puncta and the conversion of LC3-I to LC3-II induced by
palmitic acid could be significantly reduced by the chemical inhibitors of general and
conventional PKCs.,
2. There was enhanced phosphorylated PKCα in palmitic-acid-treated cells compared to the
control group. and/or
3. siRNA knock-down of PKCα reduced the level of LC3-II and autophagic flux induced by
palmitic acid [8].
Lipotoxicity is a metabolic syndrome that excessive accumulation of lipid in non-adipose cells
leads to cellular dysfunctions and death. Lipotoxicity is believed to be critically involved in
type 2 diabetes mellitus which is characterized with the decline of β-cell and insulin resistance.
Chronic exposure to elevated levels of free fatty acids leads to pancreatic β-cells lipid overload,
dysregulation of insulin secretion, and apoptotic cell death [12]. The lipotoxicity of palmitic
acid was predominant when cells were exposed to high level of saturated fatty acids. However,
palmitic-acid-mediated autophagy induction has been suggested to be a protective mechanism
against free fatty acids-induced β-cell dysfunction, apoptotic cell death, and insulin resistance
[5,13-14]. Therefore, autophagy plays a crucial role in the preservation of pancreatic β-cell
function. Further, altered autophagic activity has been implicated in the progression of obesity
to type 2 diabetes through impairment of β-cell functions and development of insulin resist‐
ance [15]. Blockage of mTOR signaling pathway with rapamycin increases the formation of
autophagosomes but attenuates palmitic-acid-induced β-cells death. On the contrary, reduc‐
tion of autophagosome formation by knocking down the ATG5, inhibition of fusion between
autophagosome and lysosome by bafilomycin A1, or inhibition of proteolytic degradation with
E64d/pepstatin A could significantly augment palmitic-acid-induced β-cells death [5].
2.1.2. Myristic acid
Myristic acid (14:0) accounts for small amounts of total fatty acids in animal tissue, but is
more abundant in milk fat and copra and palmist oils. Like other dietary saturated fatty
acids,  myristic  acid is  usually  associated with negative  consequences  for  human health.
Russo et al. [16] found that there was high expression level of LC3 and BECN1 in whole
heart lysate and increased number of LC3 puncta in left ventricles of mice fed with milk
fat-based  diet  (MFBD).  Because  of  the  high  myristate  content  of  MFBD,  the  effects  of
myristate on autophagy in isolated mouse cardiomyocytes were examined. Treatment with
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myristate  promoted  the  overexpression  of  autophagy  marker  BECN1  which  was  suffi‐
cient to increase cardiac autophagy. Furthermore, myristate led to increased formation of
GFP-LC3 puncta and the conversion of  LC3-I  to LC3-II,  suggesting the ability of  myris‐
tate to active autophagic flux in cardiomyocytes. In addition, treatment with palmitate did
not induce expression of autophagy marker, indicating that myristate but not palmitate is
responsible for the autophagy induced by MFBD [16].
The molecular mechanism underlying myristate-mediated autophagy in mouse cardiomyo‐
cytes is involved in the upregulation of C14-ceramide and ceramide synthase 5 (CerS5).
Ceramide, which is composed of sphingosine and fatty acid, is a sphingolipid bioactive
molecule that can trigger autophagy by interfering with the mTOR signaling pathway and
dissociation of the Beclin-1:Bcl-2 complex in a JNK1-mediated Bcl-2 phosphorylation-depend‐
ent manner [17]. Myristate treatment increased C14-ceramide levels 10-folds in isolated mouse
cardiomyocytes. Meanwhile, the induction of C14-ceramide was consistently observed in the
heart of mice fed with MFBD. Ceramide synthesis occurs through N-acylation of sphingoid
base by one of 6 CerS isoforms, and CerS5 is responsible for the C14-ceramide synthesis in the
mouse heart. Gain- and loss-of-function experiments demonstrated the requirement of CerS5
in sphingolipid-induced autophagy in cardiomyocytes. Overexpression of CerS5 induced
BECN1 expression in isolated cardiomyocytes even in the absence of myristate treatment.
siRNA-mediated knockdown of endogenous CerS5 abrogated the induction of BECN1
expression, the formation of GFP-LC3 puncta, and the conversion of LC3-I to LC3-II in isolated
mice cardiomyocytes treated with myristate, indicating the critical role of CerS5 in myristate-
triggered autophagy.
Autophagy has been identified as an important process upregulated in cardiac hypertrophy
and dysfunction in responses to pressure overload. However, whether autophagy plays a
beneficial or detrimental role in cardiac hypertrophy remains unclear [18]. Mice fed with
MFBD developed left ventricular hypertrophy and functional reduction in ejection fraction.
Myristate, but not palmitate, treatment increased the size of isolated cardiomyocytes, sug‐
gesting that myristate is responsible for MFBD-induced cardiac hypertrophy. In fact, myris‐
tate-induced hypertrophy could be completely prevented by LC3 knockdown or treatment
with autophagy inhibitor 3-methyladenine (3-MA), indicating that autophagy induced by
myristate plays a prohypertrophic role in cardiac lipid overload [16].
2.2. Short-chain fatty acids
Short-chains fatty (SCFAs) acids are the major byproducts of bacterial fermentation of
undigested dietary fiber within the intestinal lumen. The main SCFA production of fiber
fermentation in colon is acetate (2:0), propionate (3:0), and butyrate (4:0) in a molar ratio about
3:1:1. More than 95% of the SCFAs produced in intestine are rapidly absorbed and metabolized
by the host. SCFAs exert potent effects on a variety of colonic mucosal function such as
inhibition of inflammation reinforcing various components of colonic defense barrier and
decreasing oxidative stress. Furthermore, SCFAs have antitumor activity in the colon by
promoting apoptotic cell death [19].
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We have reported that SCFAs, particularly propionate, induced autophagy characterized by
increased LC3 puncta formation, enhanced conversion of LC3-I to LC3-II, and upregulated
expression of LAMP-2 in colon cancer cells [4]. In addition, autophagy could be induced by
butyrate in gingival epithelial cells and Chinese hamster ovary (CHO) cell, which play a
potential role of cell survival mechanism [20,21].
Treatment of colon cancer HCT116 cells with propionate led to a strong time-dependent
reduction in the phosphorylation state of mTOR at Ser2481 while there was no change in the
total mTOR levels. Phosphorylation of eukaryotic initiation factor 4E-binding proteins (4E-
BP1), a key downstream effector of mTOR activity, also markedly decreased in a dose- and
time-dependent manner after exposure to propionate. Furthermore, reduced level of phos‐
phorylated p70S6K, another key downstream effector of mTOR, was noted by 7 h following
propionate treatment. Collectively, these observations demonstrate that downregulation of
the mTOR signaling pathway is a mechanism for propionate to induce autophagy [4]. To
further characterize the mechanisms underlying the reduced mTOR activation and concomi‐
tant autophagy induction by SCFA, we examined the activation status of PI3/Akt pathway
which activates mTOR in response to the introduction of nutrient and growth factors, but no
change of the phosphorylation state of Akt at S473 or Thr308 or the total Akt were observed.
However, we observe that the AMP-activated protein kinase (AMPK), an inhibitor of the
mTOR protein, was significantly activated by propionate treatment [4], suggesting that AMPK
pathway was involved for SCFA to induce autophagy.
AMPK signaling activation induced by propionate was associated with mitochondrial defect-
mediated cellular ATP depletion and oxidative stresses. Mitochondria are organelles that
primarily produce ATP via oxidative phosphorylation in the inner membrane. Reactive
oxygen species (ROS) is an inevitable by-product of mitochondrial metabolism and can cause
mitochondrial damage. Such damage subsequently induces the mitochondrial membrane
permeability transition (MPT), mitochondria swelling, and cell death. Mitophagy, a selective
form of autophagy by which mitochondria are degraded in autolysosomes, plays an essential
role in maintaining mitochondrial functional and genetic integrity [22]. Propionate induced
ATP reduction and ROS generation in colon cancer cells due to the induction of MPT and loss
of the mitochondrial membrane potential. The proportion of mitochondria with lower
fluorescence intensity, which represents the depolarized mitochondria, was increased by
propionate treatment in a dose- and time-dependent manner in the colon cancer cells.
Furthermore, propionate treatment led to co-localization of mitochondria and GFP-LC3 puncta
in colon cancer cells. COXIV, a mitochondrial marker, was reduced and localized as defective
mitochondria by autolysosomes. An ubiquitin-binding protein-p62, which interacts with LC3
and regulates autophagosome formation, significantly co-localized with mitochondrial
COXIV. Consistently, inhibition of autophagic degradation by CQ dramatically increased the
accumulation of defective mitochondria [4]. The results suggest the ability of propionate to
induce mitophagy, which selectively targets mitochondria with a depolarized membrane
potential.
The induction of autophagy by SCFAs may serve as an adaptive strategy for colon cancer cells
to retard apoptotic cell death. Application of an autophagy inhibitor was found to enhance the
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rate of apoptosis after treatment with SCFAs. Co-treatment of HCT116 cells with propionate/
3-MA significantly reduced the percentage of GFP-LC3 formation. Meanwhile, the number of
apoptotic cells increased as indicated by the high annexin-V staining. Western blot analysis
also indicated the increased cleavages of the pro-apoptotic cascapase-7 and executioner
caspase-3. Chloroquine, another inhibitor of autophagy, enhanced apoptosis in HCT116 cells
especially at the later stages of treatment. When autophagy was inhibited with molecular
shRNA targeted to AMPKα or ATG5, there was a decreased ability of propionate to induce
GFP-LC3 puncta formation in HCT116. Consistent with the pharmacologic inhibitory experi‐
ment, AMPKα or ATG5 depletion cells displayed a significantly enhanced apoptosis after
propionate treatment [4]. The findings suggest that autophagy confers a protective role in
propionate-mediated cell death in colon cancer cells.
3. Unsaturated fatty acids
An unsaturated fatty acid is a fatty acid in which there is at least one double bond within the
hydrocarbon chain. The most common MUFAs in daily nutrition is oleic acid (18:1 n-9),
followed by palmitoleic acid (16:1 n-7) and vaccenic acid (18:1 n-7). Oleic acid could increase
the ratio of HDL to LDL cholesterol and decrease aggregation of thrombocytes. ω-3 and ω-6
PUFAs are termed as essential fatty acids because they are necessary for health but cannot be
synthesized de novo in humans. Autophagy has been reported to be induced by unsaturated
fatty acids and involved in the regulation of lipid metabolism in hepatocytes and apoptosis in
cancer cells.
3.1. Monounsaturated fatty acid
As one of the most abundant fatty acid in the diet and serum, oleic acid (18:9 n-1) is a mono‐
saturated fatty acid with the double bond at its ω-9 position. Autophagy triggered by oleate
was observed in mammary epithelial cells, hepatocytes, and osteosarcoma cells [3,23-24].
Furthermore, oleate-triggered autophagy was demonstrated by in vivo experiment. Oleate
administered via intraperitoneal injection could cause a rapid autophagic response in the heart,
liver, and skeletal muscle of mice characterized by LC3 lipidation, p62 degradation, and
phosphorylation of AMPK [23]. Treatment with oleic acid in HepG2 cells significantly
increased the number of double-membrane autophagosomes with enveloped cytosolic
contents. Meanwhile, oleic acid treatment led to the increase of GFP-LC3 puncta number in a
concentration-dependent manner, indicating that oleic acid could induce autophagy in
hepatocytes [3]. Oleic acid did not suppress mTOR activity as determined by the level of
phosphorylated 4EBP1 and p70S6K at different time points and various concentrations.
However, oleic-acid-induced autophagy required ROS formation and the classic PI3 kinase
complex. The level of ROS production was increased in oleic-acid-treated cells via activation
of the NADPH oxidase enzyme complex [25], and the number of GFP-LC3 puncta formation
induced by oleic acid could be markedly suppressed by antioxidant NAC and PI3 kinase
inhibitor.
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Autophagy triggered by oleic acid contributed to the regulation of lipids metabolism in
hepatocytes [3]. Free fatty acids taken up by hepatocytes convert into triglyceride (TG) for
storage with cholesterol in lipid droplets (LD). When energy is required, the stored TG is
hydrolyzed via activation of lipolytic pathways. Knockdown of autophagic gene ATG5
increased TG levels in hepatocytes cultured with oleate or a second endogenous stimulus for
TG formation, methionine- and choline-deficient medium (MCDM). Pharmacological inhibi‐
tion of autophagy with 3-MA also markedly increased the TG content. Consistent with the
increased TG levels, lipid staining revealed increased LD number and size in hepatocytes
cultured with oleate or MCDM that were further increased by 3-MA addition or ATG5
knockdown [26]. Autophagy did not change TG synthesis as the comparable increase in TG
synthesis occurred in ATG5 knockdown and control cells in response to oleate or MCDM.
However, ATG5 knockdown led to much lesser increase in the rate of β-oxidation, inductive
of the level of free fatty acids generated by TG hydrolysis as well as significant decrease in TG
breakdown in hepatocytes cultured in oleate or MCDM [26]. The regulation of lipid metabo‐
lism by autophagy is further supported by the association of autophagic pathway components
with LDs. Oleate treatment increased co-localization of LDs with the lysosome-associated
membrane protein type 1 (LAMP1). Inhibition of autophagosome formation with 3-MA or
autophagosome–lysosome fusion with vinblastine markedly reduced LD/LAMP1 co-locali‐
zation. Moreover, LD co-localization with autophagosome marker LC3 demonstrates a direct
association between LDs and autopaghosomes.
Niso-Santano et al. [23] reported recently that oleate-induced non-canonical autophagy in
human osteosarcoma U2OS cells required an intact Golgi apparatus. Oleate treatment
promoted the co-localization of LC3 with several proteins of trans-Golgi network including
trans-Golgi network protein 2 (TGOLN2) and galactose-1-phosphateuridylytransferase
(GALT). Similarly, GFP-LC3 puncta induced by oleate co-localized with lectin mannose-
binding 1 (LMAN1), a marker of the endoplasmic reticulum–Golgi intermediate compartment
and RAB7A, a protein residing in late endosomes. In addition, transmission electron micro‐
scopy assessment confirmed the co-localization of vacuolar structures induced by oleate with
the Golgi apparatus to the nuclear periphery. Although the disruption of Golgi apparatus
could induce autophagy in human cell lines [27], the structural and functional integrity of
Golgi apparatus were not affected by the administration of oleate. Moreover, disruption of
Golgi apparatus with brefeldin A reduced the ability of oleate to promote autophagic activity,
suggesting that oleate possesses the capacity to stimulate autophagic responses but does not
compromise the integrity of the Golgi apparatus.
3.2. ω-3 polyunsaturated fatty acids
Omega-3 PUFAs docosahexaenoic acid (DHA, 22:6 n-3) and eicosapentaenoic acid (EPA,
20:5n-3), which are found primarily in cold-water fish and fish oils, reduce the incidence and
progress of a series of human diseases including cancer. The ability of DHA and EPA to induce
autophagy has been reported in myocardioblasts and diverse human cancer cells [28-32]. DHA
treatment dramatically increased the formation of visualized autophagic vacuoles and LC3
puncta. The number of lysotracker-positive vesicles as well as the co-localization of LC3 with
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lysotracker was also markedly increased. Chloroquine promoted the induction of LC3-I by
DHA. These results collectively suggest that DHA triggers autophagy via activation of the
autophagic flux [30]. Dietary DHA and EPA could be converted to their ethanolamide
derivatives, docosahexenoyl ethanolamine (DHEA) and eicosapentaenoyl ethanolamine
(EPEA). The level of autophagy gene Beclin-1 in breast cancer cell MCF-7 could be significantly
increased after treatment with DHEA or EPEA. Furthermore, ethanolamides reduced the
association between Beclin-1 and Bcl-2, indicating that DHEA and EPEA could induce
autophagy in human breast cancer cells [33].
The molecular mechanism underlying DHA-triggered autophagy is related to the p53/AMPK/
mTOR signal pathway. The tumor suppressor p53 plays a dual role in the control of autophagy.
On one hand, nuclear p53 can induce autophagy through transcriptional effects. On the other
hand, cytoplasmic p53 may acts as a master repressor of autophagy [34]. Tissues from adult
mice with an expression of a GFP-LC3 transgene on a p53–/– background showed a higher
level of GFP-LC3 puncta than p53+/+ and heterozygous littermate. Consistently, inhibition of
p53 with siRNA or pharmacological inhibitor in human cancer cell induced the accumulation
of GFP-LC3 puncta. In human cervical and breast tumor cell lines, DHA dose-dependently
downregulated the level of p53 and triggered autophagy through a signaling pathway similar
to p53 inhibition mediated autophagy. When p53 degradation was inhibited by MG132, the
accumulation of GFP-LC3 puncta induced by DHA was significantly reduced, indicating that
loss of p53 is responsible for DHA-induced autophagy in cancer cells.
The AMPK/mTOR signaling pathway is responsible for p53 inhibition mediated autophagy.
In p53–/– cells, AMPK and its substrates tuberous sclerosis complex 2 (TSC2) and acetyl CoA
carboxylase (ACCα) were hyperphosphorylated whereas p70S6K was hypophosphorylated.
siRNA-mediated depletion of AMPKα1 and AMPKα2 or inhibition of mTOR with rapamycin
eliminated the difference in autophagy between p53-inhibited and control cells [34]. DHA
treatment increased the level of phosphor–AMPK and phosphor–ACCα expression and
decreased the activity of mTOR pathway, suggesting that DHA induces autophagy through
p53-mediated AMPK/mTOR signaling.
Autophagy induced by EPEA and DHEA in breast cancer cells has been attributed to the
activation of proliferator-activated receptor gamma (PPARγ). DHA and EPA as well as their
ethanolamide derivatives act as the activator of PPARγ, which has been reported to induce
autophagy in breast cancer cells [35]. PPARγ modulates the transcription of phosphatase and
tensin homolog on chromosome ten (PTEN), a unique phosphatase with the ability to decrease
the levels of phosphorylated AKT and consequently AKT-mediated pathway [36]. Via trans-
activation of PPARγ in MCF7 cells, DHEA and EPEA enhanced PTEN protein levels and
subsequently decreased the activity of AKT/mTOR signaling pathway which is responsible
for the induction of autophagy [33].
Omega-3 PUFAs can induce apoptosis by activating both intrinsic and extrinsic apoptotic
pathways. DHA-induced autophagy contributes to the cytotoxic activity by enhancing
apoptosis in cancer cells. While it is generally accepted that autophagy function as a mecha‐
nism for cells to survive from stresses, there is also a substantial body of literature suggesting
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that autophagy can promote cell death under certain circumstances [37,38]. Autophagy might
degrade cellular components so that the cell eventually activates the apoptosis machinery.
DHA-induced apoptosis could be partially blocked when autophagy was inhibited by 3-MA.
Consistently, ATG5 and ATG7 knockdown by siRNA reduced both autophagy and apoptosis
response to DHA treatment in human cancer cells, indicating that autophagy enhances DHA-
induced apoptosis and inhibition of autophagy prevents DHA-apoptotic cell death [30].
3.3. ω-6 polyunsaturated fatty acids
Omega-6 PUFAs are characterized by the presence of at least two carbon–carbon double bonds
with the first bond at the sixth carbon from the methyl terminus. The ability of omega-6 PUFA
to induce autophagy was observed in C. elegans [39]. As in mammalian cells, autophagy occurs
at basal levels during normal growth conditions in C. elegans, but is rapidly upregulated in
response to certain environmental stresses. Using C. elegans that express the GFP::LGG-1
reporter as an integrated transgene, autophagy was found to be activated by starvation in the
pharyngeal muscle. Enrichment of ω-3 PUFA EPA and ω-6 PUFAs arachidonic acid (AA, 20:4
n-6) and di-homo-γ-linoleic acid (DGLA, 20:3 n-6) was observed in fasted C. elegans. Supple‐
mentation with AA and DGLA, but not with EPA, was sufficient to activate autophagy in C.
elegans, indicating the role of ω-6 PUFAs in starvation-triggered autophagy. The C. elegans fatty
acid desaturases fat-6 and fat-7 are required for long-chain unsaturated fatty acids synthesis,
and fat-1 is required for the conversion of ω-6 to ω-3 PUFAs. RNAi targeted to fat-6, fat-7, or
fat-1 does not affect the intensity or distribution of LGG1 puncta in well-fed animals, suggest‐
ing that the effects of ω-6 PUFAs on autophagy is achieved only when their levels relative to
fatty acids are above a certain threshold, which cannot be recapitulated by inactivating the
enzymes responsible for the synthesis of ω-6 PUFAs or their conversion to ω-3 PUFAs [39].
Autophagy can contribute lifespan extension of C. elegans. Mutations in the insulin-like growth
factor (IGF-1) receptor DAF-2 display an increase in adult C. elegans longevity. However,
autophagy inactivation by RNAi of BEC-1 (the ortholog of Beclin-1), ATG7, and LGG3 (the
ortholog of ATG12) decreased lifespan of DAF-2 mutants, indicating that autophagy genes are
required for lifespan extension [40]. Dietary restriction plays an evolutionarily conserved role
in lifespan extension in yeasts, flies, mammals, and C. elegans. The correlation between
increased autophagy and lifespan in feeding-defective C. elegans, eat-2, eat-3, and pha-3,
provides a clue that autophagy might be involved in dietary restriction-mediated lifespan
extension [41,42]. Chronic long-term dietary supplementation with AA and DGLA extended
C. elegans lifespan under the condition of food abundance. Inactivation of the essential
autophagy genes BEC-1, LGG-1 (the ortholog of ATG8/MAPLC3), and ATG16.2 (the ortholog
of ATG16p/ATG16l1) suppressed the life extension induced by ω-6 PUFAs. These results
collectively revealed that ω-6 PUFAs increased C. elegans lifespan through the activation of
autophagy in well-fed condition. While the mechanisms by which autophagy mediates
lifespan extension are not yet understood, the possibility is that autophagy removes damaged
mitochondria, decreased levels of intracellular reactive oxygen species, and subsequently
protects against oxidative damage. Many of the long-lived mutants in C. elegans were resistant
to oxidative stress and many mutations that decrease mitochondrial electron transport are
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long-lived whereas, conversely, mutations that increase oxidative damage shorten lifespan in
C. elegans. Thus, longevity in C. elegans may be mediated either by mutations that directly affect
cellular generation or breakdown of reactive oxygen species or indirectly decrease reactive
oxygen specified via upregulation of autophagic turnover of damaged organelles that generate
these harmful species.
ω-6 PUFAs are supposed to induce autophagy in mammalian cells. Dietary supplementation
of ω-6 PUFAs improve several human conditions that overlap with the pathologies associated
with autophagy malfunctions such as chronic inflammation, neuro-degenerative disease, and
cancer. Supplementation with AA and DGLA but not EPA leads to the increase of autophagic
marker LC3-II and the formation of LC3 puncta in HeLa cells accompanied with the decreased
level of p62 [39]. Furthermore, the number of LC3 puncta in HeLa cells treatment with AA or
DGLA could be augmented by the inhibition of lysosomal enzymes and impaired by the
inactivation of autophagy gene ATG161L indicated the ability of ω-6 PUFAs to trigger
autophagy in HeLa cells via activation autophagic flux.
3.4. Trans fatty acids
Trans fatty acids (TFA) have one or more double bonds in trans configuration instead of the
usual cis configuration. The primary dietary trans TFAs are vaccenic acid (18:1 n-7t) and elaidic
acid (18:1 n-9t). Vaccenic acid is a naturally occurring TFA found in the fat of ruminants and
diary products, whereas elaidic acid is the major TFA found in hydrogenated vegetable oils
[43]. TFAs increase LDL and decrease the beneficial HDL levels resulting in a less desirable
LDL/HDL ratio, indicating the deleterious effects of TFAs consumption on human health.
Extensive evidence has proved the direct connection of TFAs with coronary heart disease,
cancer, Alzheimer’s disease, diabetes, and other diseases. TFAs-induced autophagy in primary
rat cardiac myofibroblasts has been recently reported [44]. Both vaccenic acid and elaidic acid
could induce autophagosome formation, LC3 lipidation, LC3-II formation, increased beclin-1
concentration and ATG5–ATG12 complex formation. Considering that inhibition of lysosome–
autophagosome fusion with bafilomycin A1 further increased TFAs-mediated LC3-II forma‐
tion, the authors believe that TFAs-triggered autophagy is related to de novo autophagosome
formation and subsequent turnover [44].
TFAs treatment led to marked apoptotic cell death of primary cardiac myofibroblasts, which
is dependent upon the activation of autophagy [44]. Both vaccenic acid and elaidic acid
induced cell death in a concentration-dependent manner. Meanwhile, caspase-3 and 9, but not
caspase-8 or Bid, were activated by TFAs treatment, indicating that the intrinsic apoptosis was
induced by TFAs. The role of autophagy in TFAs-induced apoptosis was confirmed in ATG3
and ATG5 knockout mouse embryonic fibroblasts (MEFs). Absence of ATG3 and ATG5
significantly reduced the cytotoxic effects of TFAs. Moreover, ATG3 or ATG5 knockout
decreased the activation of caspase 3 and caspase 7 induced by TFAs exposure, demonstrating
that autophagy is necessary for TFAs-induced apoptotic cell death [44]. As TFAs treatment led
to the generation of ROS and decreased mitochondrial membrane potential [45], it has been
hypothesized that the mechanism underlying the interplay between autophagy and apoptosis
upon TFAs treatment may be related to the disruption of the mitochondrial metabolism and
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membrane potential which serves as a powerful trigger for the induction of apoptosis and
autophagy.
3.5. Conjugated fatty acids
Conjugated fatty acids (CFAs) are a mixture of positional and geometric isomers of polyun‐
saturated fatty acids with conjugated double bonds. The most abundant fatty acids with a
conjugated system of double bonds are isomers of linoleic acid (conjugated linoleic acid, CLA),
which are found mostly in the meat and dairy products derived from ruminants. Several CLA
isomers exist due to positional and geometrical isomerism of the conjugated double bonds and
the major naturally existing one of which is referred to as 9Z11E-18:2 [1]. Most recently, CLA
has been reported to induce nonalcoholic steatohepatitis in an animal model. The liver of
mouse feeding with CLA-containing diet displayed more LC3-positive cells compared with
those fed with control diet, indicating the ability of CLA to increase autophagy in liver cells [46].
In addition to CLA, many other CFAs occur naturally in plant seeds and marine algae. Alpha-
eleostearic acid (ESA, 9Z11E13E-18:3) is a linolenic acid isomer with a conjugated triene system.
ESA makes up approximately 80% of the fatty acids in tung oil and 60% of bitter gourd seed
oil. Autophagy induction by ESA was observed in Hela cells as evidenced by the autophagic
vacuoles as well as the conversion of LC3-I to LC3-II [47]. ESA decreases phosphorylation of
P70KS and AKT effectively in both time- and dose-dependent manner. On the contrary,
ERK1/2 phosphorylation could be increased by ESA treatment, indicating that autophagy
induced by ESA is involved in the regulation of ERK1/2 and AKT/mTOR signal pathway [47].
Although ESA possesses strong suppressive effects on tumor growth, the induction of
autophagy by ESA functions as a protective mechanism against cell death in HeLa cells. When
autophagy was inhibited with 3-MA, the viability of HeLa cell was markedly reduced in
response to ESA treatment [47].
4. Conclusion
Fatty acids are important molecules with multiple physiological properties including serving
as major metabolic fuel, essential components of all membranes, and gene regulators. As an
evolutionarily conserved catabolic process, autophagy is generally thought as a survival
mechanism in dealing with stress by clearing damaged proteins, organelles, or pathogens or
by providing the cells with energy and anabolic building blocks during starvation. Autophagy
could be triggered by fatty acids and contributes to the pathologic and physiological processes
mediated by fatty acid such as the metabolism of lipid, lipotoxicity, life extension, and
antitumor activity (Figure 1). While the regulation of ROS generation, ceramide synthesis, and
multiple signal pathways like AKT/mTOR, JNK, and PKC are involved in fatty-acids-induced
autophagy, the molecular mechanisms involved and the implications in different physiological
or pathological processes need to be further elucidated.
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Multiple signaling pathways are involved in fatty-acids-mediated autophagy. JNK is respon‐
sible for autophagy triggered by long-chain saturated fatty acids, palmitic acid and myristic
acid. ROS plays an essential role in autophagy regulation through AMPK/mTOR pathway.
SCFA, TFA, oleic acid, and ω-6 PUFA-mediated autopahgy is attributed to the increase of ROS
via disruption of mitochondrial metabolism, or activation of NADPH oxidase enzyme
complex. ω-3 PUFAs induce autophagy through p53-dependent AMPK/mTOR signaling.
Other signaling pathways such as AKT/mTOR and PKCα are also involved in autophagy
regulation by fatty acids. Autophagy triggered by fatty acids contributes to diverse patholog‐
ical and physiological processes including apoptosis of cancer cells, β cell protection and
insulin resistance, life extension, lipid metabolism, and cardiac hypertrophy.
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Figure 1. The regulation of autophagy by fatty acids and its biological significances.
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